IP Library › Granted Patent US 8,119,801
Granted Patent B2
US 8,119,801 · App. 12/690,673 · Granted Feb 21, 2012

HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,801
App. No.
12/690,673
Granted
Feb 21, 2012
Kind
B2
Abstract

HIV replication inhibitors of formula pharmaceutically acceptable addition salts; or stereochemically isomeric forms thereof, wherein R 1 is halo; R 2 and R 3 each independently are C 1-6 alkyl; pharmaceutical compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.

Claims (4)

1. A compound of formula

or a pharmaceutically acceptable addition salt thereof, wherein

R 1 is bromo;

R 2 and R 3 are methyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2015
From: JANSSEN R & D IRELAND
To: JANSSEN SCIENCES IRELAND UC
Reel/Frame 035496/0382 →
CHANGE OF NAME Recorded Apr 15, 2015
From: TIBOTEC PHARMACEUTICALS
To: JANSSEN R&D IRELAND
Reel/Frame 035439/0981 →